Ezequiel Neimark

3.2k citations
50 papers · 926 indexed · 1 hit paper · h-index 10

Ezequiel Neimark

48 papers receiving 904 citations

Hit Papers

Guideline for the Evaluation of Cholestatic Jaundice in I...296201620262019202250100150200250

Peers

Ezequiel Neimark
Comparison fields: 5 of 69
  • Hepatology 128
  • Oncology 368
  • Surgery 590
  • Epidemiology 288
  • Pediatrics, Perinatology and Child Health 158
Replace Audrey Weber with:
Audrey Weber United States
Yasuaki Takeyama Japan
Jūratė Kondrackienė Lithuania
Emmanuel Jacquemin France
Bruce Y. Tung United States
Andrzej Białek Poland
J Ribalta Chile
G Sauter Germany
Alastair Baker United Kingdom
Gerda Rudolph Germany
Ezequiel Neimark relative to Audrey Weber United States Audrey Weber's profile →
Citations per field
00.5×6.4×
Audrey Weber · 1×
Citations per year

Countries citing papers authored by Ezequiel Neimark

Since Specialization
Citations

This map shows the geographic impact of Ezequiel Neimark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ezequiel Neimark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ezequiel Neimark more than expected).

Fields of papers citing papers by Ezequiel Neimark

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ezequiel Neimark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ezequiel Neimark. The network helps show where Ezequiel Neimark may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ezequiel Neimark, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ezequiel Neimark Line = papers co-authored together Ezequiel Neimark links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20242
2 20242
3 20242
4 20241
5 20244
6 20241
7 20242
8 20243
9 20249
10 202410
11 20235
12 20239
13 20231
14 20237
15 20232
16 202111
17 200648
18 20057
19 20043
20 20034

About Ezequiel Neimark

Ezequiel Neimark is a scholar working on Genetics, Gastroenterology and Immunology, having authored 50 papers that have together received 926 indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (35 papers), Eosinophilic Esophagitis (16 papers), Microscopic Colitis (15 papers), Immunodeficiency and Autoimmune Disorders (14 papers), Pediatric Hepatobiliary Diseases and Treatments (8 papers), Drug Transport and Resistance Mechanisms (5 papers), Autoimmune and Inflammatory Disorders (5 papers) and Autoimmune and Inflammatory Disorders Research (5 papers). The work is most often cited by research in Hepatology (128 citations), Oncology (368 citations) and Surgery (590 citations). Ezequiel Neimark has collaborated with scholars based in United States, Canada and Belgium. Frequent co-authors include Benjamin L. Shneider, Xiaoping Li, Frank Chen, Valérie A. McLin, Björn Fischler, Cara L. Mack, Ulrich Baumann, Udeme D. Ekong, Jean P. Molleston and Saul J. Karpen. Their work appears in journals such as Gastroenterology, Hepatology and PEDIATRICS.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026